A novel CCR4 antagonist induces potent anti-tumor response through inhibition of Treg migration into the tumor microenvironment

被引：0
|
作者：
Nair, Rashmi
Abbineni, Chandrasekhar
Talluri, Krishna Chaitanya
Dhudashiya, Amit A.
Aravind, A. B.
Kumar, Naveen R.
Ramya, R.
Balasubramanyam, D.
Obanna, Pathur
Madhaiyan, Rabin
Samiulla, D. S.
Daginakatte, Girish
Narayanan, Kishore
Nellore, Kavitha
Chelur, Shekar
Samajdar, Susanta
Ramachandra, Murali
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-6537
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6537
引用
收藏
页数：2
相关论文
共 50 条
  • [21] PARP-inhibition with IFNg in the ovarian tumor microenvironment induces immunogenic cancer cell death for sustained anti-tumor immunity.
    Kinjyo, Ichiko
    Adams, Sarah F.
    JOURNAL OF IMMUNOLOGY, 2022, 208 (01):
  • [22] Intralesional Injection of Rose Bengal Induces an Anti-tumor Immune Response and Potent Tumor Regressions in a Murine Model of Colon Cancer
    Pardiwala, K.
    Qiao, G.
    Sundararajan, J.
    Prabhakar, B.
    Maker, A. V.
    ANNALS OF SURGICAL ONCOLOGY, 2015, 22 : S86 - S86
  • [23] Inhibition of Nr4a receptors breaks Treg-mediated suppression of anti-tumor immunity
    Hibino, Sana
    Yoshimura, Akihiko
    CYTOKINE, 2017, 100 : 187 - 188
  • [24] Potent anti-tumor immune response and tumor growth inhibition induced by HER2 subdomain fusion protein in a mouse tumor model
    Ghaedi, Mojgan
    Golsaz-Shirazi, Forough
    Bahadori, Tannaz
    Khoshnoodi, Jalal
    Mortezagholi, Sahar
    Jeddi-Tehrani, Mahmood
    Amiri, Mohammad Mehdi
    Shokri, Fazel
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (06) : 2437 - 2450
  • [25] Potent anti-tumor immune response and tumor growth inhibition induced by HER2 subdomain fusion protein in a mouse tumor model
    Mojgan Ghaedi
    Forough Golsaz-Shirazi
    Tannaz Bahadori
    Jalal Khoshnoodi
    Sahar Mortezagholi
    Mahmood Jeddi-Tehrani
    Mohammad Mehdi Amiri
    Fazel Shokri
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 2437 - 2450
  • [26] ICOS agonism induces potent immune activation and anti-tumor response in non-clinical models
    Yadavilli, Sapna
    Zhang, Tianqian
    Hahn, Ashleigh
    Seestaller-Wehr, Laura M.
    Shi, Hong
    Liu, Yao-Bin
    DeYoung, M. Phillip
    Kilian, David J.
    Bi, Meixia
    Adam, Michael P.
    Zhang, Shu-Yun
    Bhattacharya, Sabyasachi
    Katlinskaya, Yuliya
    Blackwell, Christina
    Hopson, Christopher B.
    Yanamandra, Niranjan
    Srinivasan, Roopa
    Mayes, Patrick A.
    Hoos, Axel
    CANCER RESEARCH, 2017, 77
  • [27] CCR2 blockade alters the tumor microenvironment immune infiltrate and enhances anti-tumor activity in ovarian cancer
    Binder, P. S.
    Cullinan, D.
    Nywening, T.
    Wilkinson-Ryan, I.
    Belt, B.
    Goedegebuure, P.
    Powell, M. A.
    Mutch, D. G.
    Hawkins, W.
    GYNECOLOGIC ONCOLOGY, 2017, 145 : 36 - 36
  • [28] Vaccination enhances anti-tumor immunity in ovarian cancer following repolarization of the tumor microenvironment with CCR2 blockade
    Cullinan, Darren
    Binder, Pratibha
    Nywening, Timothy
    Wilkinson-Ryan, Ivy
    Belt, Brian
    Goedegebuure, Peter
    Linehan, David
    Powell, Matthew
    Hawkins, William
    CANCER RESEARCH, 2016, 76
  • [29] Vaccination Enhances Anti-tumor Immunity in Pancreatic Adenocarcinoma Following Repolarization of the Tumor Microenvironment with CCR2 Blockade
    Cullinan, D. R.
    Nywening, T.
    Panni, R.
    Belt, B.
    Fields, R. C.
    Hawkins, W.
    Linehan, D. C.
    ANNALS OF SURGICAL ONCOLOGY, 2016, 23 : S158 - S158
  • [30] Anti-tumor activity of SC-042, a highly potent synthetic analogue of intervenolin, targeting tumor microenvironment
    Kawada, Manabu
    Yoshida, Junjiro
    Ohishi, Tomokazu
    Amemiya, Masahide
    CANCER SCIENCE, 2024, 115 : 68 - 68
12345